10,000 cancer patients to get tumor DNA profiled in hunt for targeted treatments
NCT ID NCT02534649
First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 29 times
Summary
This study aims to analyze the genetic makeup of tumors from 10,000 adults with advanced solid tumors or blood cancers. By identifying specific genetic changes, doctors hope to match patients to targeted therapies in early-phase trials. The goal is to make cancer treatment more personalized and effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Centre Eugène Marquis
ACTIVE_NOT_RECRUITINGRennes, France
-
Centre Hospitalier de Pau
NOT_YET_RECRUITINGPau, 64000, France
Contact
-
Centre Hospitalier de la Côte Basque
RECRUITINGBayonne, 64000, France
Contact
-
Clinique Marzet
RECRUITINGPau, 64000, France
Contact
-
Clinique Tivoli-Ducos
RECRUITINGBordeaux, 33000, France
Contact Email: •••••@•••••
Contact
-
Institut Bergonie
RECRUITINGBordeaux, 33076, France
Contact
-
Polyclinique Bordeaux Nord Aquitaine
RECRUITINGBordeaux, 33077, France
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors choose more effective treatments for advanced cancer by matching drugs to a patient's tumor's genetic profile.
What could go wrong
This is an observational profiling study, not a treatment trial. It may not lead to better outcomes for all participants, and finding a genetic target does not guarantee an effective drug is available.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.